These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762 [TBL] [Abstract][Full Text] [Related]
12. TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing. Davidson Y; Amin H; Kelley T; Shi J; Tian J; Kumaran R; Lashley T; Lees AJ; DuPlessis D; Neary D; Snowden J; Akiyama H; Arai T; Hasegawa M; Bandopadhyay R; Sikkink S; Pickering-Brown S; Mann DM Acta Neuropathol; 2009 Sep; 118(3):359-69. PubMed ID: 19330339 [TBL] [Abstract][Full Text] [Related]
13. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184 [TBL] [Abstract][Full Text] [Related]
14. FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations. Storey K; Johanidesová S; Matěj R; Keller J; Rohan Z; Rusina R Neurocase; 2017 Feb; 23(1):5-11. PubMed ID: 27915581 [TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology. Kersaitis C; Halliday GM; Xuereb JH; Pamphlett R; Bak TH; Hodges JR; Kril JJ Neuropathol Appl Neurobiol; 2006 Feb; 32(1):83-91. PubMed ID: 16409556 [TBL] [Abstract][Full Text] [Related]
19. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Sampathu DM; Neumann M; Kwong LK; Chou TT; Micsenyi M; Truax A; Bruce J; Grossman M; Trojanowski JQ; Lee VM Am J Pathol; 2006 Oct; 169(4):1343-52. PubMed ID: 17003490 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]